ABT
Abbott Laboratories
101.30$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.0% | -2.7% | +4.1% | +2.5% | +3.2% | -5.6% | +7.6% | +2.0% | +0.8% | -2.6% | +12.8% | – | |
| – | -2.5% | -0.8% | +2.6% | +2.7% | +3.2% | -8.6% | -1.2% | +3.6% | -2.2% | -0.8% | +8.4% | – | |
| – | +4.4% | -4.5% | +5.6% | +2.3% | +3.2% | -2.8% | +15.5% | +0.8% | +3.1% | -3.9% | +16.3% | – | |
| – | +4.4% | -1.0% | +2.0% | +2.3% | +2.1% | -3.4% | +4.1% | +7.2% | -6.4% | +2.9% | +16.7% | – | |
| – | +1.6% | +8.6% | -0.8% | -1.4% | +0.4% | +5.3% | +0.9% | -1.3% | +2.6% | +19.5% | – | – | |
| – | +1.1% | +7.2% | -0.5% | -0.3% | +0.0% | +4.1% | +12.8% | +1.7% | -0.5% | +3.6% | +24.3% | – | |
| – | +11.1% | -25.7% | +21.7% | +7.8% | +9.5% | -15.2% | +21.6% | +0.2% | +9.4% | -18.2% | -3.3% | – | |
| – | +58.8% | -50.2% | +43.6% | -1.2% | -8.4% | -11.8% | -9.7% | -63.6% | +172.7% | +45.0% | +71.8% | – | |
| – | +7.4% | -20.0% | +11.9% | +20.7% | +4.6% | -12.4% | +20.9% | +1.4% | +8.2% | -38.5% | +5.2% | – | |
| – | -14.5% | +5.0% | +44.5% | -3.6% | -2,548.6% | – | -18.1% | +44.5% | +8.6% | -36.1% | +60.2% | – | |
| – | +11.0% | -23.1% | +6.3% | +26.4% | +460.7% | -85.6% | +34.3% | -7.6% | +8.0% | -39.4% | -13.8% | – | |
| – | +7.6% | -17.1% | +9.4% | +12.7% | +2.8% | -10.7% | +14.2% | +1.4% | -8.7% | -20.4% | -20.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.